Gelesis

Gelesis
Private
Industry Healthcare, Biotechnology
Founded 2008
Headquarters Boston, Massachusetts
Key people
John LaMattina, PhD – Chairman, Yishai Zohar, PhD - CEO and Founder, Robert W. Armstrong, PhD – Chief Business Officer
Website http://www.gelesis.com/

Gelesis is a privately held biotechnology company located in Boston, Massachusetts.[1] The company is developing orally administered medical devices made out of food ingredients that, when taken with water, expand in the stomach to give a feeling of satiety. The particles mix with food, keeping it in the stomach longer and slowing the absorption of nutrients in the small intestine.[2] Gelesis' first investigational device, Gelesis100, is currently in proof of concept clinical studies for the treatment of obesity.[3][4][5]

History

Gelesis was founded by PureTech Ventures.[6] The company’s technology is based around technology out of the University of Salento in Italy.[2] Alessandro Sannino, a professor of engineering at the University of Salento, is a co-inventor of the technology.[1] Gelesis has raised $42 million to date through four rounds of funding, with the most recent round of $12M announced in May 2014 with PureTech Ventures, Pritzker/Vlock Family Office, and other undisclosed investors participating.[7]

References

External links

This article is issued from Wikipedia - version of the Wednesday, September 03, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.